Events & Presentations
Upcoming Events
- Upcoming Events
- Archive
-
Dec 12, 2023 at 11:00 AM EST2023 R&D Update and ASH Data Review
Genmab will host its 2023 R&D Update and ASH Data Review virtually on Tuesday, December 12, 2023.
This meeting is not an official program of the ASH Annual Meeting.
Dec 31, 2023Financial Calendar Year EndJan 30, 2024Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsFeb 14, 2024Publication of the Annual Report for 2023 (after 5:00 PM CET)Mar 13, 2024Annual General Meeting 2024May 2, 2024Publication of the Interim Report for the First Quarter 2024 (after 5:00 PM CEST)Aug 1, 2024Publication of the Interim Report for the First Half 2024 (after 5:00 PM CEST)Nov 6, 2024Publication of the Interim Report for the First Nine Months 2024 (after 5:00 PM CET)Dec 31, 2024Financial Calendar Year End -
Nov 16, 2023 at 11:00 AM CETJefferies Healthcare ConferenceFireside Chat with Chief Executive Officer, Jan van de Winkel, and Chief Financial Officer, Anthony Pagano.Nov 7, 2023Publication of the Interim Report for the first nine months 2023
Genmab announced its financial results for the first nine months of 2023 on November 7, 2023.
Sep 12, 2023 at 3:35 PM EDTMorgan Stanley 21st Annual Global Healthcare ConferenceFireside Chat with Chief Executive Officer Jan van de Winkel and Chief Financial Officer Anthony Pagano.Aug 3, 2023Publication of the Interim Report for the first half 2023 (after 5:00 PM CEST)Jun 13, 2023 at 2:20 PM EDTGoldman Sachs 44th Annual Global Healthcare ConferenceFireside Chat with Chief Financial Officer, Anthony Pagano.May 10, 2023Publication of the Interim Report for the first quarter 2023 (after 5:00 PM CEST)Mar 29, 2023Annual General Meeting 2023Genmab A/S’ 2023 Annual General Meeting took place on Wednesday, March 29, 2023.Feb 22, 2023Publication of the Annual Report for 2022On February 22, Genmab announced its full year 2022 financial results.
Feb 14, 2023Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 11, 2023 from 9:00 AM to 9:40 AM PST41st Annual J.P. Morgan Healthcare ConferenceDec 31, 2022Financial Calendar Year EndDec 12, 2022 at 8:00 PM EST2022 R&D Update and ASH Data ReviewGenmab hosted its 2022 R&D Update and ASH Data Review on Monday, December 12, 2022.
This meeting was not an official program of the ASH Annual Meeting.
Nov 17, 2022 at 1:20 PM CETJefferies London Healthcare ConferenceFireside Chat with Chief Executive Officer, Jan van de Winkel and Chief Financial Officer, Anthony Pagano.
Nov 9, 2022Publication of the Interim Report for the First Nine Months 2022 (after 5:00 PM CET)On Nov. 9, Genmab announced financial results for the first nine months of 2022.Aug 10, 2022Publication of the Interim Report for the First Half 2022 (after 5:00 PM CEST)On Aug 10, Genmab announced financial results for the first six months of 2022.
Jun 15, 2022 at 4:20 PM EDTGoldman Sachs 43rd Annual Global Healthcare ConferenceFireside Chat with Chief Financial Officer, Anthony Pagano and Chief Development Officer, Judith Klimovsky.May 11, 2022Publication of the Interim Report for the First Quarter 2022 (after 5:00 PM CEST)On May 11, Genmab announced financial results for the first three months of 2022.
Mar 29, 2022 at 2:00 PM CESTAnnual General Meeting 2022The Annual General Meeting 2022 took place on Tuesday, March 29.Feb 16, 2022Publication of the Annual Report for 2021 (after 5:00 PM CET)On February 16, Genmab announced its full year 2021 financial results.
Feb 14, 2022Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 12, 2022 from 9:00 AM to 9:40 AM EST40th Annual J.P. Morgan Healthcare Conference -
-